LENZ Therapeutics (LENZ) Assets (2020 - 2026)

LENZ Therapeutics (LENZ) has 7 years of Assets data on file, last reported at $272.5 million in Q1 2026.

• Assets for Q1 2026 came in at $272.5 million, up 35.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $272.5 million (up 35.42% YoY), and the FY2025 annual result was $305.9 million, up 42.07% from the prior year.
• Assets fell to $272.5 million in Q1 2026 per LENZ's latest filing, from $305.9 million in the prior quarter.
• Over five years, Assets peaked at $378.6 million in Q1 2022 and troughed at $70.4 million in Q4 2023.
• A 5-year average of $258.2 million and a median of $266.2 million in 2023 frame the typical range for Assets.
• The sharpest annual moves came in 2023 and 2024: Assets tumbled 78.14% in 2023, then jumped 205.93% in 2024.
• A 5-year view of Assets shows it stood at $321.9 million in 2022, then plunged by 78.14% to $70.4 million in 2023, then jumped by 205.93% to $215.3 million in 2024, then surged by 42.07% to $305.9 million in 2025, then fell by 10.9% to $272.5 million in 2026.
• Business Quant data shows LENZ's Assets at $272.5 million in Q1 2026, $305.9 million in Q4 2025, and $210.7 million in Q3 2025.